Pharmacokinetic barriers to oxfendazole flukicidal efficacy
Laura Ceballos, Candela Canton, Valeria Gayo, Laura Moreno, Carlos Lanusse, Luis Alvarez · 2026
Read Pharmacokinetic barriers to oxfendazole flukicidal efficacy by Laura Ceballos, Candela Canton, Valeria Gayo, Laura Moreno, Carlos Lanusse, Luis Alvarez (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0355551.txt.
Description
Laura Ceballos and colleagues studied why a deworming drug, oxfendazole, kills liver flukes in sheep only at high doses, by tracing the drug from dose to blood to parasite. Their 2026 pharmacology study treated fluke-infected sheep at the standard worming dose or six times higher, then measured drug levels in plasma over time and inside the flukes themselves.
Blood exposure rose roughly fivefold at the high dose, and the flukes soaked up more than three times as much drug. That accumulation gap mirrors the drug's known jump in fluke-killing power at the higher dose. Liver fluke burdens livestock and people in many regions, so understanding the dose-to-parasite chain helps design treatments that actually reach the worm.
Catalog record
| CREATOR | Laura Ceballos, Candela Canton, Valeria Gayo, Laura Moreno, Carlos Lanusse, Luis Alvarez |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 39570 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |